Clinical Skin has acquired Glytone from Pierre Fabre Laboratories, which reiterates a continued commitment to enhancing its unrivaled product portfolio and expanding its presence in the skin care industry.
Glytone has built a reputation for delivering clinically proven skincare formulations designed to address various dermatological concerns, including aging, hyperpigmentation and the treatment of acne.
Jaime Castle, CEO at Clinical Skin, said, "We are extremely excited to welcome Glytone into the Clinical Skin family. This acquisition aligns perfectly with our mission to continue to scale our offering of skin care solutions that are firmly backed by science and innovation. Glytone's commitment to quality and efficacy complements our own values, and we are excited to work together to further elevate our product offerings."
Lisa Morris, CEO Pierre Fabre USA, said, "We are proud of the legacy we have built at Glytone over the past two decades and are confident that joining Clinical Skin’s portfolio will allow the brand to reach new heights. Hand in hand with Clinical Skin, we will now focus on assuring on a smooth transition of the brand to the benefit of patient and dermatologists alike."
!['Mented is a very strong addition to the West Lane platform of beauty and wellness businesses, and we are excited to work with [co-founder] KJ [Miller] and the team to continue providing high quality products to Mented's loyal customer base,' said Michael Wentz, a vice president at West Lane.](https://img.gcimagazine.com/files/base/allured/all/image/2024/04/370162342_682917563865368_4553016856103776370_n.66268d872fb63.png?auto=format%2Ccompress&fit=crop&h=191&q=70&rect=0%2C0%2C1080%2C1080&w=340)
